These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 9792673)

  • 1. SPARC (BM-40, osteonectin) inhibits the mitogenic effect of vascular endothelial growth factor on microvascular endothelial cells.
    Kupprion C; Motamed K; Sage EH
    J Biol Chem; 1998 Nov; 273(45):29635-40. PubMed ID: 9792673
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of SPARC by VEGF in human vascular endothelial cells.
    Kato Y; Lewalle JM; Baba Y; Tsukuda M; Sakai N; Baba M; Kobayashi K; Koshika S; Nagashima Y; Frankenne F; Noël A; Foidart JM; Hata RI
    Biochem Biophys Res Commun; 2001 Sep; 287(2):422-6. PubMed ID: 11554745
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Roles of two VEGF receptors, Flt-1 and KDR, in the signal transduction of VEGF effects in human vascular endothelial cells.
    Kanno S; Oda N; Abe M; Terai Y; Ito M; Shitara K; Tabayashi K; Shibuya M; Sato Y
    Oncogene; 2000 Apr; 19(17):2138-46. PubMed ID: 10815805
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A unique signal transduction from FLT tyrosine kinase, a receptor for vascular endothelial growth factor VEGF.
    Seetharam L; Gotoh N; Maru Y; Neufeld G; Yamaguchi S; Shibuya M
    Oncogene; 1995 Jan; 10(1):135-47. PubMed ID: 7824266
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of vascular endothelial growth factor induced mitogenesis of human endothelial cells by a chimeric anti-kinase insert domain-containing receptor antibody.
    Zhu Z; Lu D; Kotanides H; Santiago A; Jimenez X; Simcox T; Hicklin DJ; Bohlen P; Witte L
    Cancer Lett; 1999 Mar; 136(2):203-13. PubMed ID: 10355750
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vascular endothelial growth factor regulates endothelial cell survival through the phosphatidylinositol 3'-kinase/Akt signal transduction pathway. Requirement for Flk-1/KDR activation.
    Gerber HP; McMurtrey A; Kowalski J; Yan M; Keyt BA; Dixit V; Ferrara N
    J Biol Chem; 1998 Nov; 273(46):30336-43. PubMed ID: 9804796
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vascular endothelial growth factor (VEGF) receptor II-derived peptides inhibit VEGF.
    Piossek C; Schneider-Mergener J; Schirner M; Vakalopoulou E; Germeroth L; Thierauch KH
    J Biol Chem; 1999 Feb; 274(9):5612-9. PubMed ID: 10026178
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Placenta growth factor stimulates MAP kinase and mitogenicity but not phospholipase C-gamma and migration of endothelial cells expressing Flt 1.
    Landgren E; Schiller P; Cao Y; Claesson-Welsh L
    Oncogene; 1998 Jan; 16(3):359-67. PubMed ID: 9467961
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fibroblast growth factor receptor-1 mediates the inhibition of endothelial cell proliferation and the promotion of skeletal myoblast differentiation by SPARC: a role for protein kinase A.
    Motamed K; Blake DJ; Angello JC; Allen BL; Rapraeger AC; Hauschka SD; Sage EH
    J Cell Biochem; 2003 Oct; 90(2):408-23. PubMed ID: 14505356
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peptides encoded by exon 6 of VEGF inhibit endothelial cell biological responses and angiogenesis induced by VEGF.
    Jia H; Jezequel S; Löhr M; Shaikh S; Davis D; Soker S; Selwood D; Zachary I
    Biochem Biophys Res Commun; 2001 Apr; 283(1):164-73. PubMed ID: 11322784
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NCK and PAK participate in the signaling pathway by which vascular endothelial growth factor stimulates the assembly of focal adhesions.
    Stoletov KV; Ratcliffe KE; Spring SC; Terman BI
    J Biol Chem; 2001 Jun; 276(25):22748-55. PubMed ID: 11278553
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Utilization of distinct signaling pathways by receptors for vascular endothelial cell growth factor and other mitogens in the induction of endothelial cell proliferation.
    Wu LW; Mayo LD; Dunbar JD; Kessler KM; Baerwald MR; Jaffe EA; Wang D; Warren RS; Donner DB
    J Biol Chem; 2000 Feb; 275(7):5096-103. PubMed ID: 10671553
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complete inhibition of vascular endothelial growth factor (VEGF) activities with a bifunctional diabody directed against both VEGF kinase receptors, fms-like tyrosine kinase receptor and kinase insert domain-containing receptor.
    Lu D; Jimenez X; Zhang H; Wu Y; Bohlen P; Witte L; Zhu Z
    Cancer Res; 2001 Oct; 61(19):7002-8. PubMed ID: 11585724
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cysteine-rich and basic domain HIV-1 Tat peptides inhibit angiogenesis and induce endothelial cell apoptosis.
    Jia H; Lohr M; Jezequel S; Davis D; Shaikh S; Selwood D; Zachary I
    Biochem Biophys Res Commun; 2001 May; 283(2):469-79. PubMed ID: 11327725
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kinase insert domain receptor (KDR) extracellular immunoglobulin-like domains 4-7 contain structural features that block receptor dimerization and vascular endothelial growth factor-induced signaling.
    Tao Q; Backer MV; Backer JM; Terman BI
    J Biol Chem; 2001 Jun; 276(24):21916-23. PubMed ID: 11399777
    [TBL] [Abstract][Full Text] [Related]  

  • 16. De novo expression of vascular endothelial growth factor in human pancreatic cancer: evidence for an autocrine mitogenic loop.
    von Marschall Z; Cramer T; Höcker M; Burde R; Plath T; Schirner M; Heidenreich R; Breier G; Riecken EO; Wiedenmann B; Rosewicz S
    Gastroenterology; 2000 Nov; 119(5):1358-72. PubMed ID: 11054395
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vascular endothelial growth factor.
    Zachary I
    Int J Biochem Cell Biol; 1998 Nov; 30(11):1169-74. PubMed ID: 9839443
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of vascular endothelial growth factor-associated tyrosine kinase activity with SU5416 blocks sprouting in the microvascular endothelial cell spheroid model of angiogenesis.
    Haspel HC; Scicli GM; McMahon G; Scicli AG
    Microvasc Res; 2002 May; 63(3):304-15. PubMed ID: 11969307
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mapping of the sites for ligand binding and receptor dimerization at the extracellular domain of the vascular endothelial growth factor receptor FLT-1.
    Barleon B; Totzke F; Herzog C; Blanke S; Kremmer E; Siemeister G; Marmé D; Martiny-Baron G
    J Biol Chem; 1997 Apr; 272(16):10382-8. PubMed ID: 9099677
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The neurotransmitter dopamine inhibits angiogenesis induced by vascular permeability factor/vascular endothelial growth factor.
    Basu S; Nagy JA; Pal S; Vasile E; Eckelhoefer IA; Bliss VS; Manseau EJ; Dasgupta PS; Dvorak HF; Mukhopadhyay D
    Nat Med; 2001 May; 7(5):569-74. PubMed ID: 11329058
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.